Medical devices used in women’s health are under increasing medico-legal scrutiny and several devices are subject to increasing regulatory oversight or have been/are being removed from the market. Our expert panel will explore this controversy from recent events to the future.
CYPRESS, Calif. (PRWEB) November 05, 2018
AAGL (American Association of Gynecologic Laparoscopists) is excited to announce that it will present its first “Late Breaking News” session during the upcoming 47th Annual Global Congress on Minimally Invasive Gynecologic Surgery (MIGS), November 11-15, 2018 at the MGM Grand Hotel and Convention Center in Las Vegas, Nevada. This session is titled “Where Have All the Devices Gone? Presentation and Panel Discussion: The Evolution of Medical Device Regulation and Litigation,” and will be presented in a special session on Thursday, November 15, 2018 at 7:00am – 9:00am in the Premier Ballroom. It will be followed by the annual Congress’s traditional final General Session of live surgeries broadcast from operating rooms all over the world into the ballroom in high definition via cutting edge telesurgery technology. This year’s international surgical presentations will be performed in Italy, Switzerland, Australia, and Japan, with an additional surgical presentation in Massachusetts.
The “Late Breaking News” session will focus on the “ever-increasing scrutiny” that medical devices, especially those developed for use in the treatment of women’s health, have become subject to in recent years. The session aims to explore the “development of medical device regulation and litigation, starting with the silicone breast implant saga to present day controversies including uterine power morcellators, pelvic floor mesh, the Essure™ device and vaginal rejuvenation.” Panel members will additionally discuss the “impact of traditional and social media on public perception, regulation, and litigation” and how this has potentially created media bias. Further in the area of medical device product liability, the session will aim to explain the “emergence of third-party funding and its effect on mass tort/product liability litigation,” and will look to scrutinize the “disparity between science and the law.” The session will feature lectures on the above topics by panel members and will conclude with a panel discussion titled “Where Do We Go from Here” that will explore the role of the surgeon, the medical device industry, the FDA, the media, professional medical societies and litigators, and a question and answer session.
The addition of this “Late Breaking News” session shows AAGL’s commitment to bringing its members the most current developments in the field of women’s health and minimally invasive gynecologic surgery. The panel members will be comprised of physicians from across the country: Dr. Amy Brown and Dr. Bruce Kahn from San Diego, California; Dr. Stacey Scheib from New Orleans, Louisiana; and Dr. Eric Sokol from Stanford, California; and attorney Christopher Campbell, a partner at DLA Piper in Atlanta, Georgia.
“Medical devices used in women’s health are under increasing medico-legal scrutiny and several devices are subject to increasing regulatory oversight or have been/are being removed from the market,” says Dr. Dr. Marie Fidela R. Paraiso, FACOG, FPMRS, the AAGL’s 2018 Scientific Program Committee Chair and Vice President of the AAGL Board of Directors. “Our expert panel will explore this controversy from several perspectives, highlighting recent events and where the future may lie.”
AAGL’s congress is the premier scientific conference for gynecologic surgeons from around the world, offering the latest education and best practices in MIGS. This year the congress is expected to welcome over 2,000 physicians, both domestic and international, for the collegial 5-day gathering, which features 2 days of postgraduate (PG) courses offering CME (continuing medical education) credits and 3 days of high-quality, evidence-based presentations in both CME and non-CME sessions. Additionally, almost 80 companies will be exhibiting, and 1,000 industry representatives and executives will be in attendance, as the AAGL global congress is the ideal conference for medical device and technology innovation and product launches.
About the AAGL:
The AAGL (http://www.aagl.org) is the first and one of the largest organizations in the world dedicated to gynecologic endoscopic surgery. Founded in 1971, AAGL works to advance the safest and most efficacious diagnostic and therapeutic techniques that afford less invasive treatments for gynecologic conditions through the integration of clinical practice, research, and innovation. For the past 47 years, the organization has educated the world’s finest surgeons while improving the lives of women everywhere. For more information visit http://www.aagl.org.